Virtual Reality on Perception of Pain and Anxiety by Hysteroscopy

NCT03827824 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2023-05-19

No results posted yet for this study

Summary

Randomized intervention trial with a calculated sample size of 90 women aged between 18 and 75 years and medical criteria for performing a diagnostic hysteroscopy according to the Gynecology and Obstetrics Spanish Society (SEGO).

Nowadays the investigators known that acute pain requires cognitive attention for its perception, a patient's state of anxiety depends on the subjective capacity to cope with the process and that environments created with virtual reality can cause a cognitive distraction that diminishes the perception of pain as well as a subjective psychological illusion that diminishes the anxiety that motivates the procedure.

For all the above, the investigators will study as a main objective the differences between the use of virtual reality through the use of virtual reality glasses "Oculus go model", to reduce the perception of pain and anxiety motivated by the performance of a outpatient hysteroscopy versus clinical practice. It is usual not to use analgesia, using the VAS pain scale and the STAI (State-Trait Anxiety Inventory) questionnaire to assess the state of anxiety before and after the test. In addition, as secondary objectives, the investigators will compare different aspects such as surgical time used, determination of vital signs, satisfaction studies ...

Conditions

  • Uterine Diseases

Interventions

DEVICE

Hysteroscopy & virtual reality glasses

Hysteroscopy. Virtual reality glasses. VAS. STAI scale.

DEVICE

Hysteroscopy

Hysteroscopy. VAS. STAI scale.

Sponsors & Collaborators

  • Jesús Pelazas Hernández

    collaborator UNKNOWN
  • David Varillas Delgado

    collaborator UNKNOWN
  • Ignacio Cristóbal García

    collaborator UNKNOWN
  • Teresa González Casado

    collaborator UNKNOWN
  • Ignacio Cristóbal Quevedo

    collaborator UNKNOWN
  • Agustina Alonso Bermejo

    collaborator UNKNOWN
  • Marina Ronchas Martínez

    collaborator UNKNOWN
  • Universidad Francisco de Vitoria

    lead OTHER

Principal Investigators

  • Jesús V Pelazas Hernández, MD · Hospital El Escorial

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-30
Primary Completion
2019-10-30
Completion
2020-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03827824 on ClinicalTrials.gov